Mandate

Vinge advises Altor, the founders and the other sellers in connection with the divestment of a majority share in Eleda to Bain Capital

Vinge advises Altor Funds (“Altor”), the founders and the other sellers in connection with Bain Capital Private Equity (“Bain Capital”), a leading global private investment firm, acquiring a controlling stake in Eleda from Altor, which will reinvest a minority share. Eleda’s founders, Johan Halvardsson and Peter Condrup, and senior executives in Eleda will also reinvest a substantial share. Through the transaction, Altor, Eleda and Bain Capital establish a partnership for future expansion.

Headquartered in Stockholm and with approximately 3,000 employees, Eleda is a leading Nordic infrastructure development and services provider. The company is the market leader within several segments, many addressing the need of the green transition, including water and sewerage, power distribution, district heating, roads, data centres, railways, and electric vehicle charging stations. Eleda’s decentralised operating model allows its group companies to deliver the highest quality to their customers with the optimal mix of local presence and the resources of a larger organization.

The transaction is subject to regulatory approvals.

Vinge’s team consisted mainly of Christina Kokko, Johanna Wiberg, Carl Fredrik Wachtmeister, Ellen Flygt, Philip Moré, Jonatan Stentorp, Jonas Johansson, Nina Gransäter and Johan Gavelin (M&A), Louise Brorsson Salomon and Jolinn Uhlin (Banking and Finance), Martin Johansson and Hedvig Josefson (EU Regulatory), Emy Rydén, Emelie Schoning, Gabriella Balbo, Emma Emsjö, Christoffer Widström and Fanny Askelöf (Transaction Support Coordinators).

Read the client’s press release           

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026